These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

840 related items for PubMed ID: 15661240

  • 1. Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients.
    Ryu HS, Chun M, Chang KH, Chang HJ, Lee JP.
    Gynecol Oncol; 2005 Feb; 96(2):490-5. PubMed ID: 15661240
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients.
    Chen MF, Tseng CJ, Tseng CC, Yu CY, Wu CT, Chen WC.
    Cancer J; 2008 Feb; 14(3):200-6. PubMed ID: 18536561
    [Abstract] [Full Text] [Related]

  • 3. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors.
    Kim YB, Cho JH, Keum KC, Lee CG, Seong J, Suh CO, Kim GE.
    Gynecol Oncol; 2007 Jan; 104(1):58-63. PubMed ID: 16919718
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cervical cancer: combined modality therapy.
    Grigsby PW.
    Cancer J; 2001 Jan; 7 Suppl 1():S47-50. PubMed ID: 11504285
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer.
    Havrilesky LJ, Leath CA, Huh W, Calingaert B, Bentley RC, Soper JT, Alvarez Secord A.
    Gynecol Oncol; 2004 May; 93(2):429-34. PubMed ID: 15099957
    [Abstract] [Full Text] [Related]

  • 8. Matched-case comparison for the efficacy of neoadjuvant chemotherapy before surgery in FIGO stage IB1-IIA cervical cancer.
    Kim HS, Kim JY, Park NH, Kim K, Chung HH, Kim YB, Kim JW, Kim HJ, Song YS, Kang SB.
    Gynecol Oncol; 2010 Nov; 119(2):217-24. PubMed ID: 20705335
    [Abstract] [Full Text] [Related]

  • 9. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT, Hsu JC, Liu WS, Wang AY, Huang WT, Chang TH, Pi CP, Huang CY, Huang CC, Chou PH, Chen TH.
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
    [Abstract] [Full Text] [Related]

  • 10. 20 year experience of postoperative radiotherapy in IB-IIA cervical cancer patients with intermediate risk factors: impact of treatment period and concurrent chemotherapy.
    Song S, Song C, Kim HJ, Wu HG, Kim JH, Park NH, Song YS, Kim JW, Kang SB, Ha SW.
    Gynecol Oncol; 2012 Jan; 124(1):63-7. PubMed ID: 22004904
    [Abstract] [Full Text] [Related]

  • 11. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
    Lerouge D, Touboul E, Lefranc JP, Uzan S, Jannet D, Moureau-Zabotto L, Genestie C, Antoine M, Jamali M.
    Cancer Radiother; 2004 Jun; 8(3):168-77. PubMed ID: 15217584
    [Abstract] [Full Text] [Related]

  • 12. Intraarterial cisplatin/nedaplatin and intravenous 5-fluorouracil with concurrent radiation therapy for patients with high-risk uterine cervical cancer.
    Kawase S, Okuda T, Ikeda M, Ishihara S, Itoh Y, Yanagawa S, Ishigaki T.
    Gynecol Oncol; 2006 Sep; 102(3):493-9. PubMed ID: 16478629
    [Abstract] [Full Text] [Related]

  • 13. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
    Tsai CS, Lai CH, Wang CC, Chang JT, Chang TC, Tseng CJ, Hong JH.
    Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
    [Abstract] [Full Text] [Related]

  • 14. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study.
    Eddy GL, Manetta A, Alvarez RD, Williams L, Creasman WT.
    Gynecol Oncol; 1995 Jun; 57(3):412-6. PubMed ID: 7774847
    [Abstract] [Full Text] [Related]

  • 15. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
    Monk BJ, Cha DS, Walker JL, Burger RA, Ramsinghani NS, Manetta A, DiSaia PJ, Berman ML.
    Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
    [Abstract] [Full Text] [Related]

  • 16. Concurrent chemoradiotherapy with nedaplatin after radical hysterectomy in patients with stage IB and II cervical cancer.
    Kobayashi Y, Ohara T, Wada Y, Okuda Y, Kondo H, Okuma Y, Suzuki N, Gomi H, Kiguchi K, Ishizuka B.
    J Obstet Gynaecol Res; 2009 Jun; 35(3):490-4. PubMed ID: 19527388
    [Abstract] [Full Text] [Related]

  • 17. Long-term results of maximally aggressive trimodality therapy in a high-risk subset of early-stage cervical cancer patients.
    Elliott KS, Borowsky ME, Malka ES, Scudder SA, Leiserowitz GS, Russell AH.
    J Reprod Med; 2006 May; 51(5):383-8. PubMed ID: 16779984
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of paclitaxel and carboplatin as a regimen for postoperative concurrent chemoradiotherapy of high risk uterine cervix cancer.
    Kim K, Chie EK, Wu HG, Ha SW, Kim JS, Kim IA, Lee HP.
    Gynecol Oncol; 2006 Jun; 101(3):398-402. PubMed ID: 16330087
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.